Connect with us

NEWS

Over 109m Americans receive COVID-19 vaccine booster

Published

on

COVID-19 Vaccine Boosters

OVER 109 million people living in United States have received at least one booster dose.

  That represents just 35 per cent of the total US population over the age of five and less than half of those who were double-vaccinated.

   Explaining that that 4.4 million Americans have also rolled up their sleeves for the updated COVID-19 booster shot, US health officials say more than 5 million people received the new boosters at ‘informal’ levels.

   An infectious disease epidemiologist at Johns Hopkins Bloomberg School of Public Health, Dr David Dowdy, said it is too early to predict whether demand would match up with the 171 million doses of the new boosters the US ordered for the fall.

   “No one would go looking at our flu shot uptake at this point and be like. Oh, what a disaster. If we start to see a large uptick in cases, I think we’re going to see a lot of people getting the (new COVID) vaccine,” he said.

   The new bivalent COVID booster is a half and half vaccine, made from the genetic material of the original Wuhan COVID strain and Omicron.

   This differs from the last generation of jabs that were based solely on the first COVID strain and are less effective against newer variants.

   Health experts said it is too early to predict whether demand would match up with the 171 million doses of the new boosters the US ordered for the fall.

   A temporary shortage of Moderna vaccine caused some pharmacies to cancel appointments while encouraging people to reschedule for a Pfizer vaccine.

You May Also Like:-  Oyo govt collaborates with UCH team COVID-19 campaigns

   The issue was expected to resolve as government regulators wrapped up an inspection and cleared batches of vaccine doses for distribution.

  It will be recalled that Paxlovid is an antiviral medication that is used to treat high-risk people, such as older patients.

Advertisement
Advertisement
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *